PPARγ ligands increase antileukemic activity of second- and third-generation tyrosine kinase inhibitors in chronic myeloid leukemia cells

Por Glodkowska-Mrowka, E, Manda-Handzlik, A, Stelmaszczyk-Emmel, A, Seferynska, I, Stoklosa, T, Przybylski, J, Mrowka, P
Publicado no Blood Cancer J (2016)

GRP78-targeting subtilase cytotoxin sensitizes cancer cells to photodynamic therapy

Por Firczuk, M, Gabrysiak, M, Barankiewicz, J, Domagala, A, Nowis, D, Kujawa, M, Jankowska-Steifer, E, Wachowska, M, Glodkowska-Mrowka, E, Korsak, B, Winiarska, M, Golab, J
Publicado em 2013